Osaic Holdings
TERN

Osaic Holdings’s Terns Pharmaceuticals TERN Stock Holding History

Osaic Holdings’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$138K Buy
2,624
+439
+20% +$18K ﹤0.01% 4448
2025
Q4 		$88.3K Buy
2,185
+175
+9% +$4.04K ﹤0.01% 4821
2025
Q3 		$15.7K Buy
2,010
+2,000
+20,000% +$12.8K ﹤0.01% 6092
2025
Q2 		$37 Buy
+10
New +$31 ﹤0.01% 7633
2025
Q1 		– Sell
-3,690
Closed -$20.4K – 7699
2024
Q4 		$20.4K Buy
+3,690
New +$25K ﹤0.01% 5328
2024
Q3 		– Sell
-2,299
Closed -$15.7K – 7553
2024
Q2 		$15.7K Buy
+2,299
New +$13.9K ﹤0.01% 5512

Other funds holding TERN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Osaic Holdings's TERN Position: Q1 2026 in Review

Osaic Holdings increased its Terns Pharmaceuticals (TERN) stake by 20% in Q1 2026, buying an estimated $18K and bringing the position to 2,624 shares worth $138K. The position accounts for ﹤0.01% of the portfolio, ranked #4448.

Osaic Holdings first reported a position in TERN in Q2 2024 and has held it in 6 quarters since. 317 funds tracked by Wall St. Rank hold TERN as of Q1 2026.

  • Osaic Holdings held 2,624 shares of Terns Pharmaceuticals worth $138K as of Q1 2026.
  • Osaic Holdings bought 439 Terns Pharmaceuticals shares in Q1 2026, an estimated $18K.
  • Terns Pharmaceuticals made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #4448 holding.
  • Osaic Holdings first reported a position in Terns Pharmaceuticals in Q2 2024 and has held it in 6 quarters since.
  • 317 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.